Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.

[1]  K. Lee,et al.  Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. , 1994, The New England journal of medicine.

[2]  M. Kutner,et al.  A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery , 1994 .

[3]  C. Hamm,et al.  A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) , 1994, The New England journal of medicine.

[4]  J. Reiber,et al.  A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.

[5]  K. Bailey,et al.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.

[6]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[7]  RITA-2 trial participants Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial , 1993, The Lancet.

[8]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[9]  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[10]  E. Topol,et al.  Randomized Trial of Late Elective Angioplasty Versus Conservative Management for Patients With Residual Stenoses After Thrombolytic Treatment of Myocardial Infarction , 1992, Circulation.

[11]  J. W. Kennedy,et al.  Early Mortality of Acute Myocardial Infarction in Patients With and Without Prior Coronary Revascularization Surgery: A Coronary Artery Surgery Study Registry Study , 1992, Circulation.

[12]  E. Braunwald,et al.  Predictors of Early Morbidity and Mortality After Thrombolytic Therapy of Acute Myocardial Infarction: Analyses of Patient Subgroups in the Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase II , 1992, Circulation.

[13]  P. Hartigan,et al.  A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. , 1992, The New England journal of medicine.

[14]  E. Topol,et al.  Coronary angiography after thrombolytic therapy for acute myocardial infarction. , 1991, Annals of internal medicine.

[15]  P. Peduzzi,et al.  Ten‐Year Incidence of Myocardial Infarction and Prognosis After Infarction: Department of Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery , 1991, Circulation.

[16]  M. Motro,et al.  Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction. , 1990, The American journal of cardiology.

[17]  E. Braunwald,et al.  Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. , 1990, Journal of the American College of Cardiology.

[18]  R. Califf,et al.  Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. , 1989, Circulation.

[19]  E. Gilpin,et al.  A decision scheme for coronary angiography after acute myocardial infarction. , 1989, Circulation.

[20]  D. Waters,et al.  Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery. , 1988, Journal of the American College of Cardiology.

[21]  M. Weisfeldt,et al.  Prognostic cardiac catheterization variables in survivors of acute myocardial infarction: a five year prospective study. , 1988, Journal of the American College of Cardiology.

[22]  E. Topol,et al.  A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. , 1987, The New England journal of medicine.

[23]  K. Lee,et al.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.

[24]  E. Gilpin,et al.  Prediction of late mortality after myocardial infarction from variables measured at different times during hospitalization. , 1984, The American journal of cardiology.

[25]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.

[26]  B. Pitt,et al.  Predictors of Clinical Course, Coronary Anatomy and Left Ventricular Function After Recovery From Acute Myocardial Infarction , 1980, Circulation.

[27]  W. Siegenthaler,et al.  Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.

[28]  J. Bigger,et al.  Risk stratification after acute myocardial infarction. , 1978, The American journal of cardiology.

[29]  A. Moss,et al.  The Early Posthospital Phase of Myocardial Infarction: Prognostic Stratification , 1976, Circulation.

[30]  R. Miller,et al.  Functional significance of coronary collateral vessels in patients with acute myocardial infarction: relation to pump performance, cardiogenic shock and survival. , 1976, The American journal of cardiology.